Key Takeaways
• TGA issued its Compliance Principles for 2026 and 2027, setting five enforcement directions
• Proactive advertising compliance work is set to focus on digital environments
• Enforcement targets include unapproved and falsified products across e-commerce and social media channels
• Vaping goods are listed among priority focus areas effective January 1, 2026
• TGA plans to review the priority focus areas again in March 2026
2Firsts, January 23, 2026
According to TGA, the Therapeutic Goods Administration has published the TGA Compliance Principles 2026 and 2027, setting out enforcement directions that include：
proactive scrutiny of advertising, particularly across digital environments;
action against unapproved and falsified products, including those supplied via e-commerce and social media;
improved access to compliance information through guidance and education;
action to address false and misleading online information, including social media and influencer content;
and enhanced compliance tools to address risks linked to AI-generated misinformation and deceptive endorsements, alongside a stated focus on visibility of enforcement action and non-compliance in digital channels.
The document also sets out priority focus areas. From January 1, 2026, TGA’s compliance and enforcement activity is set to focus on 12 categories of therapeutic goods, including vaping goods. TGA also notes that the next review of these priority areas is scheduled for March 2026.
TGA further states it will continue to undertake other case-based compliance activity and investigations and may take action on non-compliance regardless of whether the matter falls within a stated priority.
Image source: TGA
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
